|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Accounts receivable, net | |||||||||||||
| Accounts receivable - related parties | |||||||||||||
| Inventories | |||||||||||||
| Spare part inventories | |||||||||||||
| Spare part inventories, net | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Property, plant and equipment, net | |||||||||||||
| Operating lease right-of-use assets | |||||||||||||
| Finance lease right-of-use assets | |||||||||||||
| Goodwill | |||||||||||||
| Intangible assets, net | |||||||||||||
| Other long-term assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and stockholders' equity | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accounts payable - related parties | |||||||||||||
| Accrued liabilities | |||||||||||||
| Current portion of long-term debt | |||||||||||||
| Current portion of operating lease liabilities | |||||||||||||
| Current portion of finance lease liabilities | |||||||||||||
| Current portion of deferred revenue | |||||||||||||
| Other current liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Long-term debt, net of discount and deferred financing costs | |||||||||||||
| Deferred tax liabilities | |||||||||||||
| Operating lease liabilities | |||||||||||||
| Finance lease liabilities | |||||||||||||
| Deferred revenue | |||||||||||||
| Asset retirement obligation | |||||||||||||
| Other long-term liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Redeemable noncontrolling interest | |||||||||||||
| Stockholders' equity: | |||||||||||||
| Members' equity | |||||||||||||
| Preferred stock, $0.01 par value; 500,000,000 authorized; no shares issued and outstanding as of September 30, 2026 and December 31, 2025. | |||||||||||||
| Common Stock, $0.01 par value, 1,500,000,000 shares authorized, 125,008,936 shares and 124,111,436 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively. | |||||||||||||
| Common Class A | |||||||||||||
| Common Class B | |||||||||||||
| New Atlas Common Stock | |||||||||||||
| Total common Stock, $0.01 par value, 1,500,000,000 shares authorized, 125,008,936 shares and 124,111,436 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively. | |||||||||||||
| Additional paid-in-capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders' equity | |||||||||||||
| Total liabilities and stockholders' equity |
Loading...